193 related articles for article (PubMed ID: 18312040)
21. Antipsychotic adherence over time among patients receiving treatment for schizophrenia: a retrospective review.
Valenstein M; Ganoczy D; McCarthy JF; Myra Kim H; Lee TA; Blow FC
J Clin Psychiatry; 2006 Oct; 67(10):1542-50. PubMed ID: 17107245
[TBL] [Abstract][Full Text] [Related]
22. A Patient-Centered Antipsychotic Medication Adherence Intervention: Results From a Randomized Controlled Trial.
Pyne JM; Fischer EP; Mittal D; Owen R
J Nerv Ment Dis; 2018 Feb; 206(2):142-148. PubMed ID: 29251658
[TBL] [Abstract][Full Text] [Related]
23. Detection of non-adherent behaviour in early psychosis.
Hui CL; Chen EY; Kan CS; Yip KC; Law CW; Chiu CP
Aust N Z J Psychiatry; 2006 May; 40(5):446-51. PubMed ID: 16683971
[TBL] [Abstract][Full Text] [Related]
24. A prospective study of risk factors for nonadherence with antipsychotic medication in the treatment of schizophrenia.
Ascher-Svanum H; Zhu B; Faries D; Lacro JP; Dolder CR
J Clin Psychiatry; 2006 Jul; 67(7):1114-23. PubMed ID: 16889456
[TBL] [Abstract][Full Text] [Related]
25. Implementation of a clinical practice guideline for schizophrenia in a specialist mental health center: an observational study.
Fischler I; Riahi S; Stuckey MI; Klassen PE
BMC Health Serv Res; 2016 Aug; 16(a):372. PubMed ID: 27514778
[TBL] [Abstract][Full Text] [Related]
26. The Brief Adherence Rating Scale (BARS) validated against electronic monitoring in assessing the antipsychotic medication adherence of outpatients with schizophrenia and schizoaffective disorder.
Byerly MJ; Nakonezny PA; Rush AJ
Schizophr Res; 2008 Mar; 100(1-3):60-9. PubMed ID: 18255269
[TBL] [Abstract][Full Text] [Related]
27. Factors associated with medication adherence among patients with schizophrenia in Mekelle, Northern Ethiopia.
Eticha T; Teklu A; Ali D; Solomon G; Alemayehu A
PLoS One; 2015; 10(3):e0120560. PubMed ID: 25816353
[TBL] [Abstract][Full Text] [Related]
28. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
[TBL] [Abstract][Full Text] [Related]
29. Adherence to antipsychotics and cardiometabolic medication: association with health care utilization and costs.
Hansen RA; Maciejewski M; Yu-Isenberg K; Farley JF
Psychiatr Serv; 2012 Sep; 63(9):920-8. PubMed ID: 22706887
[TBL] [Abstract][Full Text] [Related]
30. Adherence of schizophrenia pharmacotherapy to published treatment recommendations: patient, facility, and provider predictors.
Leslie DL; Rosenheck RA
Schizophr Bull; 2004; 30(3):649-58. PubMed ID: 15631257
[TBL] [Abstract][Full Text] [Related]
31. An RCT of adherence therapy for people with schizophrenia in Chiang Mai, Thailand.
Maneesakorn S; Robson D; Gournay K; Gray R
J Clin Nurs; 2007 Jul; 16(7):1302-12. PubMed ID: 17584349
[TBL] [Abstract][Full Text] [Related]
32. Substance abuse and the management of medication nonadherence in schizophrenia.
Wilk J; Marcus SC; West J; Countis L; Hall R; Regier DA; Olfson M
J Nerv Ment Dis; 2006 Jun; 194(6):454-7. PubMed ID: 16772865
[TBL] [Abstract][Full Text] [Related]
33. Self-reported medication treatment adherence among veterans with bipolar disorder.
Sajatovic M; Bauer MS; Kilbourne AM; Vertrees JE; Williford W
Psychiatr Serv; 2006 Jan; 57(1):56-62. PubMed ID: 16399963
[TBL] [Abstract][Full Text] [Related]
34. Differential medication adherence among patients with schizophrenia and comorbid diabetes and hypertension.
Piette JD; Heisler M; Ganoczy D; McCarthy JF; Valenstein M
Psychiatr Serv; 2007 Feb; 58(2):207-12. PubMed ID: 17287377
[TBL] [Abstract][Full Text] [Related]
35. The effect of a locally adapted, secondary stroke risk factor self-management program on medication adherence among veterans with stroke/TIA.
Damush TM; Myers L; Anderson JA; Yu Z; Ofner S; Nicholas G; Kimmel B; Schmid AA; Kent T; Williams LS
Transl Behav Med; 2016 Sep; 6(3):457-68. PubMed ID: 27349906
[TBL] [Abstract][Full Text] [Related]
36. Prospective memory predicts medication management ability and correlates with non-adherence to medications in individuals with clinically stable schizophrenia.
Lam JW; Lui SS; Wang Y; Chan RC; Cheung EF
Schizophr Res; 2013 Jul; 147(2-3):293-300. PubMed ID: 23631929
[TBL] [Abstract][Full Text] [Related]
37. Early predictors of nonadherence to antipsychotic therapy in first-episode psychosis.
Rabinovitch M; Béchard-Evans L; Schmitz N; Joober R; Malla A
Can J Psychiatry; 2009 Jan; 54(1):28-35. PubMed ID: 19175977
[TBL] [Abstract][Full Text] [Related]
38. Cognitive predictors of medication adherence among middle-aged and older outpatients with schizophrenia.
Jeste SD; Patterson TL; Palmer BW; Dolder CR; Goldman S; Jeste DV
Schizophr Res; 2003 Sep; 63(1-2):49-58. PubMed ID: 12892857
[TBL] [Abstract][Full Text] [Related]
39. Medication adherence and long-term functional outcomes in the treatment of schizophrenia in usual care.
Ascher-Svanum H; Faries DE; Zhu B; Ernst FR; Swartz MS; Swanson JW
J Clin Psychiatry; 2006 Mar; 67(3):453-60. PubMed ID: 16649833
[TBL] [Abstract][Full Text] [Related]
40. How do clinical trial participants compare to other patients with schizophrenia?
Barnett PG; Scott JY; Rosenheck RA;
Schizophr Res; 2011 Aug; 130(1-3):34-9. PubMed ID: 21514794
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
